<code id='47CA143A7D'></code><style id='47CA143A7D'></style>
    • <acronym id='47CA143A7D'></acronym>
      <center id='47CA143A7D'><center id='47CA143A7D'><tfoot id='47CA143A7D'></tfoot></center><abbr id='47CA143A7D'><dir id='47CA143A7D'><tfoot id='47CA143A7D'></tfoot><noframes id='47CA143A7D'>

    • <optgroup id='47CA143A7D'><strike id='47CA143A7D'><sup id='47CA143A7D'></sup></strike><code id='47CA143A7D'></code></optgroup>
        1. <b id='47CA143A7D'><label id='47CA143A7D'><select id='47CA143A7D'><dt id='47CA143A7D'><span id='47CA143A7D'></span></dt></select></label></b><u id='47CA143A7D'></u>
          <i id='47CA143A7D'><strike id='47CA143A7D'><tt id='47CA143A7D'><pre id='47CA143A7D'></pre></tt></strike></i>

          entertainment

          entertainment

          author:leisure time    Page View:75919

          The Senate has set its eyes on regulating insurance plans for some of the most vulnerable patients in the U.S. — the 12.5 million people eligible for both Medicare and Medicaid.

          “They’re a complex group of people with a lot of chronic conditions — mental illness, frailty, disability,” said Jose Figueroa, an internal medicine physician and health policy expert at Brigham and Women’s Hospital. Over a third of these dual-eligible beneficiaries have less than a high school education, and about 90% make less than $20,000 per year.

          advertisement

          Just around 15% of beneficiaries are eligible for both Medicare and Medicaid, but they account for a third of these programs’ spending — around $440 billion — and still don’t receive better health care, Sen. Bill Cassidy (R-La.) pointed out in a JAMA viewpoint published earlier this month. “The root cause of worse outcomes despite spending more money is a lack of coordination of care,” Cassidy wrote.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more
          FDA approves Leqembi, a milestone in Alzheimer’s treatment
          FDA approves Leqembi, a milestone in Alzheimer’s treatment

          Amyloidplaquesformingbetweenneurons.AdobeTheFoodandDrugAdministrationonThursdaygrantedfullapprovalto

          read more
          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more

          Medical experts are missing from AI regulatory conversations

          SenateMajorityLeaderChuckSchumerinJuneannouncedtheSAFEInnovationframeworkto“supportresponsiblesystem